Telomir Pharmaceuticals, Inc.
Developing an oral small molecule to reverse aging and treat age-related diseases.
TELO | US
Overview
Corporate Details
- ISIN(s):
- US87975F1049
- LEI:
- Country:
- United States of America
- Address:
- 100 SE 2ND ST, 33131 MIAMI
- Website:
- https://telomirpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Telomir Pharmaceuticals, Inc. is a preclinical-stage biotechnology company focused on developing therapies to reverse biological aging and combat age-related degenerative diseases. The company's lead candidate, Telomir-1, is a novel oral small molecule designed to address the root causes of cellular aging. Its mechanism of action involves protecting and elongating telomeres—the protective caps of chromosomes—and regulating essential metals like iron and copper to defend against oxidative stress, DNA damage, and chronic inflammation. Preclinical studies are exploring its potential applications in age-reversal, conditions such as Wilson's Disease, and certain cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Telomir Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Telomir Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Telomir Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
